How the CDC Opioid Guidelines Might Affect You if You Have Chronic Pain

Whenever it comes to a controversial issue, I always ask myself: Who benefits? In most cases, it’s not all that hard to figure it out. But sometimes, it seems like…

Continue Reading How the CDC Opioid Guidelines Might Affect You if You Have Chronic Pain
Err on the Side of Caution When It Comes to This Familial Hypercholesterolemia Treatment
Source: pixabay.com

Err on the Side of Caution When It Comes to This Familial Hypercholesterolemia Treatment

According to some Finnish researchers, children with heterozygous familia hypercholesterolemia (HeFH) should use statins as a treatment with caution. Though they have proven to be able to lower lipid levels…

Continue Reading Err on the Side of Caution When It Comes to This Familial Hypercholesterolemia Treatment
ICYMI: People with IPF May Breathe Easier with New Stem Cell Treatment
https://pixabay.com/en/woman-happiness-sunrise-silhouette-570883/

ICYMI: People with IPF May Breathe Easier with New Stem Cell Treatment

If you or someone you love has been diagnosed with idiopathic pulmonary fibrosis (IPF), it's easy to become discouraged by the lack of medical options. Although almost 50,000 people a…

Continue Reading ICYMI: People with IPF May Breathe Easier with New Stem Cell Treatment
Countdown to Cleveland: Why Walking Can Make a Difference This Year for the PI Community
[Source: pixabay.com]

Countdown to Cleveland: Why Walking Can Make a Difference This Year for the PI Community

Primary immunodeficiency diseases (PI) are a group of more than 300 rare and chronic disorders where part of the body's immune system is missing or does not function properly. Since…

Continue Reading Countdown to Cleveland: Why Walking Can Make a Difference This Year for the PI Community
Is This What the MPS Research Community Been Missing?
Source: pixabay.com

Is This What the MPS Research Community Been Missing?

Recent findings from research done at the University of Pennslyvania indicate a new biomarker associated with a group of rare metabolic diseases called mucopolysaccharidoses (MPS). A biomarker is a measurable…

Continue Reading Is This What the MPS Research Community Been Missing?